Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia

Currently, the graft-versus-host disease (GVHD) prophylaxis consists of an immunosuppressive therapy mainly based on antithymocyte globulin (ATG) or post-transplant cyclophosphamide (PTCy). GVHD remains a major complication and limitation to successful allogeneic haploidentical hematopoietic stem ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Zhenli, Yan, Han, Teng, Yao, Shi, Wei, Xia, Linghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705727/
https://www.ncbi.nlm.nih.gov/pubmed/36458000
http://dx.doi.org/10.3389/fimmu.2022.1017850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705727/
https://www.ncbi.nlm.nih.gov/pubmed/36458000
http://dx.doi.org/10.3389/fimmu.2022.1017850

Ejemplares similares